Cargando…

Circulating miRNA-24 and its target YKL-40 as potential biomarkers in patients with coronary heart disease and type 2 diabetes mellitus

Type 2 diabetes mellitus (DM2) is associated with cardiovascular complications and is characterized by high levels of YKL-40, an inflammatory glycoprotein involved in endothelial dysfunction. We investigated the predictive potential of circulating miR-24 in coronary heart diseases (CHD) DM2 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Xin, Liu, Yaofang, Luo, Mao, Wu, Jian, Ma, Rongyue, Wan, Qin, Wu, Jianbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609901/ https://www.ncbi.nlm.nih.gov/pubmed/28968969 http://dx.doi.org/10.18632/oncotarget.18593

Ejemplares similares

Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus
por: Kim, Hyun Min, et al.
Publicado: (2012)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009)

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
por: Schroder, Jakob, et al.
Publicado: (2020)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Hepatitis C Virus Mediated Changes in miRNA-449a Modulates Inflammatory Biomarker YKL40 through Components of the NOTCH Signaling Pathway
por: Sarma, Nayan J., et al.
Publicado: (2012)

Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999)

YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease
por: Mavroudis, Ioannis, et al.
Publicado: (2021)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease
por: Zhang, Ping, et al.
Publicado: (2020)

The inflammatory biomarker YKL-40 decreases stepwise after exercise stress test
por: Dam Mygind, Naja, et al.
Publicado: (2016)

YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis
por: Luo, Wanwan, et al.
Publicado: (2021)

Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD
por: Wang, Jing, et al.
Publicado: (2018)

Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

Association of Circulating COMP and YKL-40 as Markers of Metabolic Changes of Cartilage with Adipocytokines in Juvenile Idiopathic Arthritis
por: Winsz-Szczotka, Katarzyna, et al.
Publicado: (2020)

Circulating miRNA-155 as a Potential Biomarker for Coronary Slow Flow
por: Su, Qiang, et al.
Publicado: (2018)

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)

Can YKL-40 be used as a biomarker for interstitial lung disease?: A systematic review and meta-analysis
por: Tong, Xiang, et al.
Publicado: (2021)

Urinary YKL-40 as a Candidate Biomarker for Febrile Urinary Tract Infection in Young Children
por: Kim, Hyun Hee, et al.
Publicado: (2018)

YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease
por: Muszyński, Paweł, et al.
Publicado: (2017)

The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review
por: Tong, Xiang, et al.
Publicado: (2018)

Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis
por: Salomon, Joanna, et al.
Publicado: (2017)

YKL-40 A Sensitive Biomarker for Early Androgenetic Alopecia and Early Hidden Metabolic Syndrome
por: Elhabak, Doaa M., et al.
Publicado: (2020)

Serum YKL-40 as a Potential Biomarker for Sepsis in Term Neonates—A Pilot Study
por: Steletou, Evangelia, et al.
Publicado: (2023)

YKL-40 is correlated with FEV(1) and the asthma control test (ACT) in asthmatic patients: influence of treatment
por: Lai, Tianwen, et al.
Publicado: (2015)

Conserved YKL-40 changes in mice and humans after postoperative delirium
por: David-Bercholz, Jennifer, et al.
Publicado: (2022)

Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT
por: Yan, Linlin, et al.
Publicado: (2018)

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
por: Shao, Rong, et al.
Publicado: (2009)

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
por: Shao, Rong
Publicado: (2013)

Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization
por: Shao, Rong, et al.
Publicado: (2015)

Effect of Vitamin D on YKL-40: Rat Hypercholesterolemia Model
por: Kocabas, Rahim
Publicado: (2023)

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer
por: Schultz, Nicolai A., et al.
Publicado: (2013)

Circulating miRNA Biomarkers for Alzheimer's Disease
por: Kumar, Pavan, et al.
Publicado: (2013)

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
por: Grasso, Margherita, et al.
Publicado: (2014)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oca973nbo2s3bpihap6bf9erd4